| Sign In to gain access to subscriptions and/or personal tools. |
A Dual-label Technique for the Immunohistochemical Demonstration of T-Lymphocyte Subsets in Formalin-fixed, Paraffin-Embedded Rat Lymphoid TissueAstraZeneca, Alderley Park, Macclesfield, Cheshire, United Kingdom Correspondence: Kevin J. Randall, AstraZeneca, 23G5 Mereside, Alderley Park, Macclesfield, Cheshire, UK, SK10 4TG; e-mail:kevin.randall{at}astrazeneca.com.
Immunotoxicology has developed into an integral regulatory requirement of the toxicological assessment of xenobiotics. Histopathological assessment of lymphoid tissues can provide genuine insight into perturbations of lymphoid cell populations. To facilitate retrospective examination of lymphoid organs should concerns over immunotoxicity be raised, we have endeavored to develop a panel of immunohistochemical techniques to demonstrate T-cells and T-cell subsets in formalin-fixed, paraffin-embedded rat lymphoid tissues. We were successful in developing methods for CD3 and CD8 but failed to arrive at a satisfactory technique for the direct demonstration of CD4 in these tissues. Taking the assumption that the majority of mature T-cells are either CD4+ orCD8+, we have combined our methods for CD3 and CD8 in a novel dual-labeling IHC method to simultaneously demonstrate CD3, CD8, and, by implication, CD4 in rat spleen, thymus, lymph node, and Peyer’s patch.
Key Words: T-lymphocyte subset • CD4 • CD8 • formalin-fixed • paraffin-embedded • immunohistochemistry • rat lymphoid tissue Abbreviations: DCU, deep cortical unit • FFPE, formalin-fixed paraffin embedded • IFR, interfollicular region • IHC, immunohistochemistry • PALS, peri-arteriolar lymphoid sheath
Immunotoxicology has developed over the past quarter of a century into an integral part of the safety evaluation of xenobiotics. This development is in part owing to the enormous body of evidence that medicinal products can exert immunotoxic effects, either by the suppression or stimulation of immune responses, and because of increasing awareness of the need for this complex issue to be consistently addressed. Immunotoxicity is an important cause of drug-related adverse events, contributing to the withdrawal of a number of drugs from the market in the past 15 years, including chlormezanone (Trancopal) (EMEA 1997; Roujeau et al. 1995), glafenine (Glifanan) (Davido et al. 1989; van der Klauw 1996), and temafloxin (Omniflox) (Woodcock 2003). Over recent years, a number of proposals have been made in an attempt to rationalize and improve histopathological assessment of the immune system (STP IWG 2005; Germolec et al. 2004; Kuper et al. 1995; Kuper et al. 2000; Kuper et al. 2002; Mitsumori et al. 1996; Ward et al. 1993). Most recently, in 2005, the International Conference on Harmonisation (ICH) Working Group, involving regulatory authorities of the European Union, Japan, and the United States, produced the ICH Harmonised Tripartite Guideline on Immunotoxicity Studies for Human Pharmaceuticals (S8) (ICH 2005). This document, restricted to unintendedimmunosuppression or immunoenhancement of human pharmaceuticals, recommends that all new human pharmaceuticals should be tested for immunotoxic potential via a tiered approach. The initial screen for potential immunotoxicity involves standard toxicity studies, including a recommendation for the semiquantitative description of changes in the separate compartments of lymphoid tissue in sections stained routinely for morphology. Based on a weight of evidence review, including results of histopathology, additional functional studies of immunocompetence may be required. Immunophenotyping (identification/enumeration) of leukocyte subsets, conducted using either flow cytometry or immunohistochemistry, is included in the additional battery of tests to be carried out when immunotoxicity is suspected from the standard studies. Some immunotoxicants, such as cylophosphamide, can induce a low dose depletion of a subset of T-cells (Male et al. 2006a) prior to exhibiting a more generalized lymphocyte toxicity at higher doses. The detection and counting of shifts in T-cell population distribution in preclinical studies is usually performed by flow cytometry on peripheral blood or disaggregated tissues or, occasionally, by immunofluorescence on sectioned organs (Janeway et al. 2005b). These techniques, however, require specialized preparative procedures with prospective sample collection and cannot be carried out retrospectively. The advantage of immunohistochemistry over flow cytometry is that tissues from standard toxicity studies can be analyzed retrospectively if concerns over immunotoxicity are raised. Since this material is routinely formalin fixed and paraffin embedded (FFPE), we felt it would be necessary to develop immunohistochemical methods that would work on routine tissue blocks. The success of IHC depends on the interaction between the primary antibody and the tissue antigen (Haines and Chelak 1991), and anything disrupting this interaction may have a detrimental effect on the quality of staining. Historically the immunohistochemical demonstration of immune tissue antigens has been performed on frozen tissue sections (Barclay 1981; Bland and Whiting 1993; Liou et al. 1996; Nano et al. 2003; Paterson et al. 1987; Robinson et al. 1986; van Ewijk et al. 1981), but the preservation of antigenic epitopes comes at the expense of morphology, and frozen sections may suffer from artifactual streaming of target sites (Beckstead 1994; Fee et al. 1996; González et al. 2001). Aldehyde-based fixatives, such as buffered formalin, are favored for the preparation of tissues for routine histology and for IHC. Fixation in buffered formalin results in excellent morphological preservation but may decrease the antigenicity of the tissue, possibly because of the protein cross-links created during aldehyde fixation (Cattoretti et al. 1993), or perhaps because of tight complexing of calcium ions or other divalent metal cations with proteins during formaldehyde tissue fixation, masking certain antigens (Morgan et al. 1994). Epitope unmasking techniques may be used to expose the hidden epitopes (Shi et al. 1997, 2001), although these techniques offer no guarantees and the optimal procedure must be determined for each individual antibody (Shi et al. 1996). This laboratory has endeavored to assemble a toolkit of IHC stains to identify immune cell populations in routinely prepared formalin-fixed, paraffin-embedded (FFPE) tissues. The demonstration of mature T-lymphocytes and the division of the totality ,of T-cells into the T-cytotoxic (TC), CD8 + and T-helper (TH) CD4+ subsets has been a challenge. Here we describe a novel method whereby T-cells may be identified in formalin-fixed, paraffin-embedded lymphoid tissues, and the relative proportions of TCto THcells demonstrated by immunohistochemistry. The equivalent staining of lymphoid tissues of nude rats was included, where possible, as a control and comparative exercise.
Tissue Sampling Lymphoid tissues including spleen, thymus, mesenteric lymph node, and Peyer’s patch were sampled from four male seven- to eight-week-old Hanover Wistar rats (Crl:WI(GIx/BRL/Han)BR, Charles River, UK). Additional lymphoid tissues including spleen, mesenteric lymph node, and Peyer’s patch were sampled from two male nude rats (Nude:HSD Han:RNU-mu, Charles River, UK). The rats were killed using an overdose of the inhalant anaesthetic agent Halothane (Nicholas Piramal, Mumbai, India). Whole organs were fixed in 10% phosphate buffered formalin, pH 7.0, for forty-eight hours. After fixation, tissues were trimmed to blocks no thicker than 3 mm, dehydrated in graded industrial methylated spirit, cleared in xylene, and processed to paraffin wax on a Shandon Excelsior Tissue Processor (Thermo Fisher Scientific, Runcorn, UK) using our standard rodent tissue schedule. All animal procedures were conducted in accordance with Home Office (UK) and local ethical review committee guidelines and complied with the Animals Scientific Procedures Act of 1986.
Pan T-lymphocyte Immunohistochemistry (CD3) Endogenous peroxidase activity was quenched by incubation in 3% hydrogen peroxide in TBST for ten minutes. Slides were then washed and incubated for twenty minutes with 5% normal goat serum (Dako UK Ltd, Ely, UK) in TBST. Excess blocking serum was blown off, and the slides were incubated with polyclonal rabbit anti-human CD3 (cat. #180102, Invitrogen, Paisley UK) diluted 1:50 in TBST for sixty minutes. Following washing, the slides were incubated for thirty minutes in rabbit-specific EnVision+ System–HRP (Dako UK Ltd, Ely, UK), and visualized by incubation in diaminobenzidine (DAB), from the EnVision+ kit, for ten minutes. The slides were counterstained for one minute using Carazzi’s hematoxylin (Clin-Tech, Guildford, UK). Staining was negatively controlled by substituting rabbit immunoglobulin (Ig) fraction, diluted to the same Ig concentration, for the primary antibody. Stained sections were dehydrated and mounted under glass coverslips with Histomount (RA Lamb, Eastbourne, UK).
Cytotoxic T-lymphocyte Immunohistochemistry (CD8)
Helper T-lymphocyte Immunohistochemistry (CD4)
Dual-labeling Immunohistochemistry (CD3/CD8) The lack of a successful method for the explicit demonstration of CD4+ THcells demanded an alternative approach. A dual stain illustrating the total CD3+ T-cell population and the CD8+ TCsubpopulation would implicitly identify the CD4+ T-lymphocytes by subtraction of the CD8+ cells from the total T-cell population. The methods described above were adapted to reduce potential stearic hindrance between antibodies and detection systems during the dual-labeling procedure. Sections 4 µm thick were prepared and dewaxed as described. Heat-mediated antigen retrieval was performed in a Milestone RHS-2 microwave at 110°C for two minutes in 1 mM EDTA buffer, pH 8.0 and endogenous peroxidase quenched. After washing, the sections were incubated for twenty minutes in serum-free protein block (cat. #X0909, Dako UK Ltd, Ely, UK). Monoclonal mouse anti-rat CD8 (clone OX-8, cat. #CBL1507, Chemicon, Chandlers Ford, UK), diluted 1:200, was applied to the sections for one hour at room temperature and the signal detected by incubation in horseradish peroxidase-conjugated donkey anti-mouse IgG (H+ L) F(ab’)2 fragments (cat. #715-036-151, Jackson Immunoresearch Laboratories, West Grove, PA, USA) diluted 1:100 for thirty minutes. Visualization was achieved by application of DAB (cat. #K3468, Dako UK Ltd, Ely, UK) for ten minutes. The slides were then rinsed thoroughly in deionized water and TBST before the re-application of serum-free protein block for twenty minutes. Polyclonal rabbit anti-CD3 (cat. #180102, Invitrogen, Paisley, UK) diluted 1:10 in TBST was applied for sixty minutes followed, after washing, by incubation in goat anti-rabbit IgG (H+ L), alkaline phosphatase conjugate (cat. #G21079, Invitrogen, Paisley, UK), diluted 1:100 for thirty minutes. Visualization of primary antibody binding was achieved by incubation in Permanent Red (cat. #K0640, Dako UK Ltd, Ely, UK) for ten minutes. The slides were counter-stained for one minute using Carazzi’s hematoxylin, and stained sections were dehydrated and mounted under glass coverslips with Histomount. Staining was negatively controlled by substituting either rabbit Ig fraction or mouse IgG1 isotype control for either one or both of the primary antibodies. The controls were diluted to the same immunoglobulin concentration as the diluted primary antibodies.
Validation of Dual-labeling Immunohistochemistry Sections 4 µm thick were stained for either CD3 or CD8 using the method detailed above for dual labeling, omitting the CD3 or CD8 primary antibodies as necessary. A dual stain of CD8 and CD3 was also performed for comparison with that executed on the formalin-fixed material. High-temperature antigen retrieval was unnecessary for tissues fixed in Z7. CD4 was demonstrated using a mouse monoclonal antibody (clone OX-38, cat. #CBL CBL1506, Chemicon, Chandlers Ford, UK), diluted 1:200. The detection method was that detailed for the single staining of CD8 given above. Image analysis and quantification were performed with the Zeiss KS400 system (Imaging Associates, Bicester, Oxfordshire, UK), linked to a Leica DMRB microscope, using a bespoke macro program. Six fields of view from each of the sections were captured using a 10X objective lens, and the area of immunohistochemical staining, brown for CD4 and CD8 or red for CD3, was measured.
Pan T-lymphocyte Immunohistochemistry (CD3) Spleen Intense membranous staining of lymphocytes was seen in the periarteriolar lymphoid sheath (PALS) in the white pulp of the Han Wistar rats stained for CD3 (Figure 1A). The follicles of the white pulp and the marginal zone, between the white and red pulp, contained approximately 10% to 20% of CD3+ cells. Almost 100% of the cells within the inner PALS were positive for CD3. The outer rim of the PALS was a combination of CD3+ and CD3– cells. There was a scattering of CD3+ lymphocytes throughout the red pulp.
In the nude rat, although the PALS area was almost completely absent, occasional CD3+ cells were observed running along the length of the splenic central arterioles (Figure1B). Within the follicles, marginal zones and red pulp CD3+ cells were identified in fewer numbers, less than 5% of the total cell population, than in the immunocompetent Han Wistar rats.
Thymus No results were obtained from the nude rats, as these animals are athymic.
Mesenteric Lymph Node The DCUs were absent from the lymph nodes of the nude rat, but the follicles, interfollicular cortex, and medulla contained occasional CD3+ cells.
Peyer’s Patch The frequency of CD3+ cells was much reduced in the nude rat and showed no concentration of positive cells within the interfollicular region.
Cytotoxic T-lymphocyte Immunohistochemistry (CD8) In the nude rat, occasional CD8+ cells were observed in the region of the splenic arterioles (Figure 1D). Within the follicles, marginal zones, and red pulp, CD8+ cells were observed, but at a reduced frequency compared with the immunocompetent Han Wistar rats.
Thymus
Mesenteric Lymph Node
Peyer’s Patch
Helper T-lymphocyte Immunohistochemistry (CD4)
Dual CD8/CD3 Immunohistochemistry
A summary of the immunohistochemical findings is given in Table 2.
Validation of Dual-labeling Immunohistochemistry The dual-staining distribution for CD8 and CD3 on the Z7 zinc-fixed tissue was comparable with that achieved with formalin-fixed spleen (Figure 4A), although the morphological preservation of the tissue was inferior.
The areas stained and quantitated for CD3, CD8, and CD4 individually (Figure 4B–4D) were:
Taking the CD3 measurement as the total T-cell population, one could calculate the populations of CD4 and CD8 in this material to be 58% and 40%, respectively. The distribution and staining patterns achieved with CD3 and CD8 in the different lymphoid tissues were consistent with our expectations. In Han Wistar rats, the pan T-cell marker CD3 stained areas of the spleen, thymus, lymph nodes, and Peyer’s patches known to be T-cell areas. CD3 is known to be weakly expressed in developing T-cells of the human thymic cortex (Male et al. 2006b), which is reflected in our results in the rat. The frequency of CD3+ cells in lymphoid tissues from the nude rat was extremely reduced. Because these animals are athymic, one might have expected a complete absence of staining for T-cells in the nude rat. There is, however, evidence for the extrathymic development and maturation of T-cells in the epithelium of the small intestine (LeFrançois and Puddington 1995; Ramanathan et al. 2002; Rocha, Vassalli et al. 1992; Rocha et al. 1995; Rocha 2007), which may provide an explanation for this observation. The distribution of the CD8+ cells mirrors that of the CD3, but at a lower frequency, labeling only the cytotoxic subset of T-cells (Patel et al. 1988).
The distinctive attribute of a mature T-lymphocyte is the expression of one of the two types of T-cell antigen receptor (TCR) (Janeway et al. 2005a). The two types of TCR take the form of two similar heterodimers consisting of either
Accepting that the overwhelming majority of T-cells express either CD4 orCD8, we suggest that if one can label the general T-cell population and the CD8+ subpopulation simultaneously, then the labeled cells that are not CD8+, that is, the cells that have stained red not brown, must, on the whole, be CD4+ T-helper cells. A simple visual assessment of control spleen suggests that, out of the total T-cell population, slightly more CD4+ cells are present than CD8+ (Figures 2Aand 2B). This assessment is corroborated by the validation work performed on Z7 zinc-fixed tissue, which measured the populations as 58% CD4+ and 40% CD8+. This dual-labeling technique therefore offers a way of visualizing the general make-up of the T-cell population on a single slide of routinely processed formalin-fixed, paraffin-embedded tissue. There are two caveats to be aware of:
The logic behind the CD3 – CD8 =CD4 equation fails for these subsets, but for the majority of T-cells within lymphoid tissues the reasoning holds true. In summary:
The investigation of the effects of xenobiotics on lymphocyte populations in FFPE tissue is an important part of the evaluation of their potential immunomodulatory effects. The comparison of staining in nude and immunocompetent Han Wistar rats (Figures 1Eand 1F) illustrates the power of this dual-labeling technique to demonstrate variations in T-lymphocyte populations between animals. Also, in addition to the semiquantitative assessment of a pathologist, we intend to investigate the feasibility of quantitative image analysis of the dual staining, either by traditional colorimetric means, or by employing multispectral imaging systems such as the Nuance (Channel Systems Inc, Pinawa, Canada). This dual-labeling IHC methodology has the advantage that it may be applied to archived wax blocks of formalin-fixed tissue many months, or even years, after the initial study, while preserving the T-cell populations within a morphological context. Alternatives to aldehyde fixation have been proposed, such as periodate-lysine-paraformaldehyde (PLP) (Whiteland et al. 1995) or zinc-salt–based fixative (ZSF) (Beckstead 1994; Hicks et al. 2006; Lykidis et al. 2007), such as the Z7 fixative used in our validation experiment. Although these fixatives do appear to be better at preserving immune cell epitopes, we have found in this laboratory the morphological preservation of ZSF to be inferior to that of buffered formalin, and PLP is unsuitable for large toxicological studies because large volumes cannot be prepared in advance and stored, rather the fixative has to be prepared immediately before use. Also, one must sample tissues into these fixatives prospectively in anticipation of performing immune cell IHC. We therefore consider this dual method of staining—which demonstrates T-cell numbers and relative populations of T-cell subsets all in one slide, from routinely prepared blocks of paraffin-embedded, formalin-fixed tissue—an informative and practical adjunct to investigations of immunotoxicity.
Barclay, AN. (1981). The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. Immunology, 42, 593-600[Web of Science][Medline] [Order article via Infotrieve] Beckstead, JH. (1994). A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J Histochem Cytochem, 42, 1127-34[Abstract] Bland, PW, & Whiting, CV. (1993). Differential control of major histocompatibility complex class II I-E Cattoretti, G, Pileri, S, Parravicini, C, Becker, MH, Poggi, S, Bifulco, C, Key, G, D’Amato, L, Sabattini, E, Feudale, E, Reynolds, F, Gerdes, J, & Rilke, F. (1993). Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol, 171, 83-98[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Chen, W, Ford, MS, Young, KJ, & Zhang, L. (2004). The role and mechanisms of double negative regulatory T cells in the suppression of immune responses. Cell Mol. Immunol, 1, 328-35[Medline] [Order article via Infotrieve] Davido, A, Hallali, P, & Boutchnei, T. (1989). Shock caused by glafenine. Apropos of 7 complications. Rev Med Interne, 10, 113-17[Web of Science][Medline] [Order article via Infotrieve] EMEA. European Medicines Agency. (1997). Final opinion of the Committee for Proprietary Medicinal Products pursuant to Article 12 of Council Directive 75/319/EEC as amended for Chlormezanone, CPMP/375/97-EN. Available at: http://www.emea.eu.int/pdfs/human/phv/EN/037597en.pdf. Fee, M, Tobin, B, Magee, H, Harrison, M, Gorey, T, & Dervan, PA. (1996). Comparison of oestrogen receptor assessment in frozen and paraffin sections. Pathol Res Pract, 192, 919-24[Web of Science][Medline] [Order article via Infotrieve] Germolec, DR, Kashon, M, Nyska, A, Kuper, CF, Portier, C, Kommineni, C, Johnson, KA, & Luster, MI. (2004). The accuracy of extended histopathology to detect immunotoxic chemicals. Toxicol Sci, 82, 504-14 González, L, Anderson, I, Deane, D, Summers, C, & Buxton, D. (2001). Detection of immune system cells in paraffin wax-embedded ovine tissues. J Comp Pathol, 125, 41-47[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Haines, DM, & Chelak, BJ. (1991). Technical considerations for developing enzyme immunohistochemical staining procedures on formalin-fixed paraffin-embedded tissue for diagnostic pathology. J Vet Diagn Invest, 3, 101-12 Hicks, DJ, Johnson, L, Mitchell, SM, Gough, J, Cooley, WA, La Ragione, RM, Spencer, YI, & Wangoo, A. (2006). Evaluation of zinc salt based fixatives for preserving antigenic determinants for immunohistochemical demonstration of murine immune system cell markers. Biotech Histochem, 81, 23-30[CrossRef][Web of Science][Medline] [Order article via Infotrieve] ICH. International Conference On Harmonisation Harmonised Tripartite Guideline. (2005). Immunotoxicity Studies For Human Pharmaceuticals S8. Available at: http://www.ich.org/LOB/media/MEDIA1706.pdf. Janeway, CA., Jr, Travers, P, Walport, M, & Shlomchik, MJ. (2005a). The Development and Survival of Lymphocytes. In Immunobiology. (6th ed) 241-316). New York: Garland Science Janeway, CA., Jr, Travers, P, Walport, M, & Shlomchik, MJ. (2005b). Appendix 1, Immunologists’Toolbox. In Immunobiology. (6th ed) 683-729). New York: Garland Science Kuper, CF, Harleman, JH, Richter-Reichhelm, HB, & Vos, JG. (2000). Histopathologic approaches to detect changes indicative of immunotoxicity. Toxicol Pathol, 28, 454-66 Kuper, CF, deHeer, E, Van Loveren, H, & Vos, JG. In Haschek, W, Rousseaux, CG, & Wallig, MA (Eds.). (2002). Immune System. In Handbook of Toxicologic Pathology, 2, (2nd ed) 585-646). San Diego: Academic Press Kuper, CF, Schuurman, H-J, & Vos, JG. In Burleson, GR, Dean, JH, & Munson, AE (Eds.). (1995). Pathology in immunotoxicology, 1, 397-436). New York: Wiley-Liss. In Methods in Immunotoxicology. LeFrançois, L. (1991). Phenotypic complexity of intraepithelial lymphocytes of the small intestine. J.Immunol, 147, 1746-51[Abstract] LeFrançois, L, & Puddington, L. (1995). Extrathymic intestinal T-cell development: virtual reality? Immunol Today, 16, 16-21[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Liou, W, Geuze, HJ, & Slot, JW. (1996). Improving structural integrity of cryosections for immunogold labeling. Histochem Cell Biol, 106, 41-58[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Lykidis, D, Van Noorden, S, Armstrong, A, Spencer-Dene, B, Li, J, Zhuang, Z, & Stamp, GW. (2007). Novel zinc-based fixative for high quality DNA, RNA and protein analysis. Nucleic Acids Res, 35, e85 Male, D, Brostoff, J, Roth, DB, & Roitt, I. (2006a). Cells, Tissues and Organs of the Immune System, In Immunology. (7th ed) 19-58). Philadelphia, PA: Mosby Elsevier Male, D, Brostoff, J, Roth, DB, & Roitt, I. (2006b). AIDS and Secondary Immunodeficiency. In Immunology. (7th ed) 311-24). Philadelphia, PA: Mosby Elsevier Mitsumori, K, Takegawa, K, Shimo, T, Onodera, H, Yasuhara, K, & Takahashi, M. (1996). Morphometric and immunohistochemical studies on atrophic changes in lympho-hematopoietic organs of rats treated with piperonyl butoxide or subjected to dietary restriction. Arch Toxicol, 70, 809-14[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Morgan, JM, Navabi, H, Schmid, KW, & Jasani, B. (1994). Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol, 174, 301-7[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Nano, R, Balegno, S, Vaccarone, R, Corato, M, & Ceroni, M. (2003). Detection of paraneoplastic anti-neuronal-specific antibodies: comparison of different immunohistochemical techniques. Anticancer Res, 23, 2377-81[Web of Science][Medline] [Order article via Infotrieve] Patel, SS, Duby, AD, Thiele, DL, & Lipsky, PE. (1988). Phenotypic and functional characterization of human T cell clones. J Immunol, 141, 3726-36[Abstract] Paterson, DJ, Jefferies, WA, Green, JR, Brandon, MR, Corthesy, P, Puklavec, M, & Williams, AF. (1987). Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 + T blasts. Mol Immunol, 24, 1281-90[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Poussier, P, Edouard, P, Lee, C, Binnie, M, & Julius, M. (1992). Thymus-independent development and negative selection of T cells expressing T cell receptor alpha/beta in the intestinal epithelium: evidence for distinct circulation patterns of gut- and thymus-derived T lymphocytes. J Exp Med, 176, 187-99 Poussier, P, & Julius, M. (1994). Thymus independent T cell development and selection in the intestinal epithelium. Annu Rev Immunol, 12, 521-53[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Ramanathan, S, Marandi, L, & Poussier, P. (2002). Evidence for the extrathymic origin of intestinal TCRgammadelta(+) T cells in normal rats and for an impairment of this differentiation pathway in BB rats. J Immunol, 168, 2182-87 Robinson, AP, White, TM, & Mason, DW. (1986). Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology, 57, 239-47[Web of Science][Medline] [Order article via Infotrieve] Rocha, B, Vassalli, P, & Guy-Grand, D. (1992). The extrathymic T-cell development pathway. Immunol Today, 13, 449-54[Web of Science][Medline] [Order article via Infotrieve] Rocha, B, Guy-Grand, D, & Vassalli, P. (1995). Extrathymic T cell differentiation. Curr Opin Immunol, 7, 235-42[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Rocha, B. (2007). The extrathymic T-cell differentiation in the murine gut. Immunol Rev, 215, 166-77[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Rocha, B, von Boehmer, H, & Guy-Grand, D. (1992). Selection of intraepithelial lymphocytes with CD8 alpha/alpha co-receptors by self-antigen in the murine gut. Proc Natl Acad Sci U S A, 89, 5336-40 Roujeau, JC, Kelly, JP, Naldi, L, Rzany, B, Stern, RS, Anderson, T, Auquier, A, Bastuji-Garin, S, Correia, O, Locati, F, et al. (1995). Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med, 333, 1600-7 Shi, SR, Cote, RJ, & Taylor, CR. (1997). Antigen retrieval immunohistochemistry: past, present, and future. J Histochem Cytochem, 45, 327-43 Shi, SR, Cote, RJ, & Taylor, CR. (2001). Antigen retrieval techniques: current perspectives. J Histochem Cytochem, 49, 931-37 Shi, SR, Cote, RJ, Yang, C, Chen, C, Xu, HJ, Benedict, WF, & Taylor, CR. (1996). Development of an optimal protocol for antigen retrieval: a ‘test battery’ approach exemplified with reference to the staining of retinoblastoma protein (pRB) in formalin-fixed paraffin sections. J Pathol, 179, 347-52[CrossRef][Web of Science][Medline] [Order article via Infotrieve] STP Immunotoxicology Working Group, Haley, P, Perry, R, Ennulat, D, Frame, S, Johnson, C, Lapointe, J-M, Nyska, A, Snyder, PW, Walker, D, & Walter, G. (2005). STP Position Paper: Best Practice Guideline for the Routine Pathology Evaluation of the Immune System. Toxicol Pathol, 33, 404-7[CrossRef][Web of Science][Medline] [Order article via Infotrieve] Thomson, CW, Lee, BP, & Zhang, L. (2006). Double-negative regulatory T cells: non-conventional regulators. Immunol Res, 35, 163-78[CrossRef][Web of Science][Medline] [Order article via Infotrieve] van der Klauw, MM, Wilson, JH, & Stricker, BH. (1996). Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974–1994) and review of the literature. Clin Exp Allergy, 26, 1355-63[CrossRef][Web of Science][Medline] [Order article via Infotrieve] van Ewijk, W, van Soest, PL, & van den Engh, GJ. (1981). Fluorescence analysis and anatomic distribution of mouse T lymphocyte subsets defined by monoclonal antibodies to the antigens Thy-1, Lyt-1, Lyt-2, and T-200. J Immunol, 127, 2594-604[Web of Science][Medline] [Order article via Infotrieve] Ward, JM, Uno, H, & Frith, CH. (1993). Immunohistochemistry and morphology of reactive lesions I. lymph nodes and spleen from rats and mice. Toxicol Pathol, 21, 199-205 Whiteland, JL, Nicholls, SM, Shimeld, C, Easty, DL, Williams, NA, & Hill, TJ. (1995). Immunohistochemical detection of T-cell subsets and other leukocytes in paraffin-embedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem, 43, 313-20[Abstract] Woodcock, J, Pfizer Inc. (2003). Withdrawal of Approval of a New Drug Application. Fed Regist, 68, 1469 Zhang, ZX, Young, K, & Zhang, L. (2001). CD3+ CD4–CD8– alphabeta-TCR+ T cell as immune regulatory cell. J Mol Med, 79, 419-27[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
This version was published on October
1, 2008 Toxicologic Pathology, Vol. 36, No. 6,
795-804 (2008)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
Top
Abstract
Introduction
and β or 
and 
polypeptides. Over 95% of mature T-cells are 
protein expression in the epithelium and in subsets of lamina propria antigen-presenting cells of the gut. Immunology, 79, 107-11